blue-check Amendments to regulations on bidding for supply of drugs for public health facilities

Circular No. 06/2023/TT-BYT dated March 12th, 2023 of the Minister of Health on providing amendments to certain Articles of the Circular No. 15/2019/TT-BYTstatus2 dated July 11, 2019 of the Minister of Health of Vietnam prescribing bidding for supply of drugs for public health facilities
Posted: 16/3/2023 7:27:34 AM | Latest updated: 8/4/2023 6:42:05 PM (GMT+7) | LuatVietnam: 5659 | Vietlaw: 606

This Circular amends, supplements to some regulations of Circular No. 15/2019/TT-BYTstatus2 regarding bidding for supply of drugs, vaccines, biological medical products, herbal ingredients. To be specific:

- Responsibility to develop and implement drug supplier selection plans at regulated at Article 4;

- Sorting of generic drug contract package regulated at Article 7;

- Criteria for selection of a contract package of original brand-name drugs regulated at clause 2 Article 8;

- Sorting of contract packages of herbal drugs, drugs containing herbal materials combined with active pharmaceutical ingredients and traditional drugs regulated at Article 9;

- Sorting of contract packages of traditional medicinal materials regulated at Article 10;

This Circular takes effect from April 27th, 2023.

To replace Clause 2 Article 3, Clause 4 Article 27, Point c Clause 3 Article 32, Point h Clause 4 Article 45 and Clause 9 Article 50 of the Circular No. 15/2019/TT-BYTstatus2 dated July 11th, 2019; Article 5 of the Circular No. 15/2020/TT-BYTstatus2 dated August 10th, 2020; Points a, b, c, dd Clause 8 Article 1 of the Circular No. 29/2020/TT-BYTstatus2 dated December 31st, 2020 .


Related documents

Penalty document



Effective Date 27-Apr-2023
ExpiredDate Unknown
Published Vietlaw's Newsletter No. 606

Files attachment

enflag pdficon TT06_12032023BYT[E].pdf


No data

Pharmaceutical - Cosmetics

blue-check Notable regulations on putting cosmetic products on market
blue-check From May 4th, 2023: Applications for marketing authorization of drugs shall be wholly submitted online
blue-check [Merged] - Regulations on Goods Manufacturing Practices for pharmaceutical products
blue-check Amendments to regulations on bidding for supply of drugs for public health facilities
blue-check Conditions for entitlement to 5% VAT with regard to imported veterinary drugs
blue-check New procedures for inspection of GMP compliance of manufacturers
blue-check List of precious, rare and endemic medicinal plant species under control
blue-check Withdrawal of 6 companies from the List of foreign companies committing drug’s quality
blue-check Amendments to principles to apply GMP standards for manufacture of pharmaceutical products and pharmaceutical starting materials
blue-check Manufacturers of veterinary drugs may apply for the GMP Certificate online
blue-check Amendments to conditions on import of veterinary drugs containing precursors
blue-check It is expected to remove procedures for confirmation of cosmetic advertisements under the 2022 - 2025 road map
blue-check Plants imported for use as medicines have to comply with regulations provided for the pharmacy sector
red-check Guidance on development of rare herb planting projects supported by the State in the 2021 - 2025 period
blue-check New regulations on drugs subject to bioequivalence study during application for marketing authorization
blue-check New regulations on marketing authorization of drugs
blue-check Advertisements for drugs’ incorrect utilities shall be stopped
blue-check List of foreign companies having drugs that do not conform to quality standards (phase 36)
blue-check Principles of selection of control drugs used for bioequivalence study